{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:40:46Z","timestamp":1790800846687,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":42,"publisher":"Springer New York","isbn-type":[{"value":"9781493994236","type":"print"},{"value":"9781493994243","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9424-3_32","type":"book-chapter","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T12:03:34Z","timestamp":1559822614000},"page":"531-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Chronic Granulomatous Disease"],"prefix":"10.1007","author":[{"given":"Dirk","family":"Roos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,7]]},"reference":[{"key":"32_CR1","first-page":"773","volume-title":"Hematology of infancy and childhood","author":"M Dinauer","year":"2015","unstructured":"Dinauer M, Newburger P, Borregaard N (2015) Phagocyte system and disorders of granulopoiesis and granulocyte function. In: Nathan DG, Orkin SH (eds) Hematology of infancy and childhood. Elsevier\/Saunders, Philadelphia, pp 773\u2013847"},{"key":"32_CR2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/tra.12115","volume":"14","author":"P Nunes","year":"2013","unstructured":"Nunes P, Demaurex N, Dinauer MC (2013) Regulation of the NADPH oxidase and associated ion fluxes during phagocytosis. Traffic 14:1118\u20131131","journal-title":"Traffic"},{"key":"32_CR3","unstructured":"Van de Geer et al (2018) J Clin Invest 128:3957\u20133975"},{"key":"32_CR4","first-page":"689","volume-title":"Primary immunodeficiency diseases, a molecular and genetic approach","author":"D Roos","year":"2014","unstructured":"Roos D, Holland SM, Kuijpers TW (2014) Chronic granulomatous disease. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases, a molecular and genetic approach, 3rd edn. Oxford University Press, New York, pp 689\u2013722","edition":"3"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.jaci.2014.10.039","volume":"135","author":"OK Alkhairy","year":"2015","unstructured":"Alkhairy OK, Rezaei N, Graham RR et al (2015) RAC2 loss-of-function mutation in two siblings with characteristics of common variable immunodeficiency. J Allergy Clin Immunol 135:1380\u20131384","journal-title":"J Allergy Clin Immunol"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/bmb\/ldw009","volume":"118","author":"D Roos","year":"2016","unstructured":"Roos D (2016) Chronic chranulomatous disease. Br Med Bull 118:53\u201366","journal-title":"Br Med Bull"},{"key":"32_CR7","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"DB Kuhns","year":"2010","unstructured":"Kuhns DB, Alvord WG, Heller T et al (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363:2600\u20132610","journal-title":"N Engl J Med"},{"key":"32_CR8","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","volume":"132","author":"MY K\u00f6ker","year":"2013","unstructured":"K\u00f6ker MY, Camc\u0131o\u011flu Y, van Leeuwen K et al (2013) Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol 132:1156\u20131163","journal-title":"J Allergy Clin Immunol"},{"key":"32_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ajh.24573","volume":"92","author":"B Wolach","year":"2017","unstructured":"Wolach B, Gavrieli R, de Boer M et al (2017) Chronic granulomatous disease: Clinical, functional, molecular, and genetic studies. The Israeli experience with 84 patients. Am J Hematol 92:28\u201336","journal-title":"Am J Hematol"},{"key":"32_CR10","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1084\/jem.180.6.2329","volume":"180","author":"JH Leusen","year":"1994","unstructured":"Leusen JH, Bolscher BG, Hilarius PM et al (1994) 156Pro-->Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med 180:2329\u20132334","journal-title":"J Exp Med"},{"key":"32_CR11","volume":"5","author":"D Roos","year":"2014","unstructured":"Roos D, van Buul JD, Tool AT et al (2014) Two CGD families with a hypomorphic mutation in the activation domain of p67phox. J Clin Cell Immunol 5:pii:1000231","journal-title":"J Clin Cell Immunol"},{"key":"32_CR12","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1074\/jbc.270.12.6543","volume":"270","author":"AR Cross","year":"1995","unstructured":"Cross AR, Curnutte JT (1995) The cytosolic activating factors p47-phox and p67-phox have distinct roles in the regulation of electron flow in NADPH oxidase. J Biol Chem 270:6543\u20136548","journal-title":"J Biol Chem"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr et al (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155\u2013169","journal-title":"Medicine (Baltimore)"},{"key":"32_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005234","volume":"4","author":"JM Berg Van den","year":"2009","unstructured":"Van den Berg JM, van Koppen E, Ahlin A et al (2009) Chronic granulomatous disease: the European experience. PLoS One 4:e5234","journal-title":"PLoS One"},{"key":"32_CR15","first-page":"231","volume-title":"Chronic granulomatous disease: genetics, biology and clinical management","author":"D Roos","year":"2017","unstructured":"Roos D, Tool AT, van Leeuwen K et al (2017) Biochemical and genetic diagnosis of chronic granulomatous disease. In: Seger R, Roos D, Segal B, Kuijpers TW (eds) Chronic granulomatous disease: genetics, biology and clinical management. Nova Publishers, New York, pp 231\u2013300"},{"key":"32_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bcmd.2010.07.012","volume":"45","author":"D Roos","year":"2010","unstructured":"Roos D, Kuhns DB, Maddalena A et al (2010) Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis 45:246\u2013265","journal-title":"Blood Cells Mol Dis"},{"key":"32_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/humu.22519","volume":"35","author":"M Boer de","year":"2014","unstructured":"de Boer M, van Leeuwen K, Geissler J et al (2014) Primary immunodeficiency caused by an exonized retroposed gene copy inserted in the CYBB gene. Hum Mutat 35:486\u2013496","journal-title":"Hum Mutat"},{"key":"32_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bcmd.2017.08.012","volume":"66","author":"M Boer De","year":"2017","unstructured":"De Boer M, van Leeuwen K, Geissler J et al (2017) Mutation in an exonic splicing enhancer site causing chronic granulomatous disease. Blood Cells Mol Dis 66:50\u201357","journal-title":"Blood Cells Mol Dis"},{"key":"32_CR19","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1172\/JCI119721","volume":"100","author":"A G\u00f6rlach","year":"1997","unstructured":"G\u00f6rlach A, Lee P, Roesler J et al (1997) A p47-phox pseudogene carries the most common mutation causing p47-phox deficient chronic granulomatous disease. J Clin Invest 100:1907\u20131918","journal-title":"J Clin Invest"},{"key":"32_CR20","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.bbadis.2013.05.001","volume":"1832","author":"A Hayrapetyan","year":"2013","unstructured":"Hayrapetyan A, Dencher PC, van Leeuwen K et al (2013) Different unequal cross-over events between NCF1 and its pseudogenes in autosomal p47(phox)-deficient chronic granulomatous disease. Biochim Biophys Acta 1832:1662\u20131672","journal-title":"Biochim Biophys Acta"},{"key":"32_CR21","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bcmd.2010.01.009","volume":"44","author":"D Roos","year":"2010","unstructured":"Roos D, Kuhns DB, Maddalena A et al (2010) Hematologically important mutations: The autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis 44:291\u2013299","journal-title":"Blood Cells Mol Dis"},{"key":"32_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/jmedgenet-2017-105022","volume":"55","author":"M Boer De","year":"2018","unstructured":"De Boer M, Gavrieli R, van Leeuwen K et al (2018) A false-carrier state for the c.579G>A mutation in the NCF1 gene in Ashkenazi Jews. J Med Genet 55:166\u2013172","journal-title":"J Med Genet"},{"key":"32_CR23","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1182\/blood-2009-07-231498","volume":"114","author":"JD Matute","year":"2009","unstructured":"Matute JD, Arias AA, Wright NA et al (2009) A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 114:3309\u20133315","journal-title":"Blood"},{"key":"32_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood.V100.3.1026","volume":"100","author":"R Bruggen Van","year":"2002","unstructured":"Van Bruggen R, Bautista JM, Petropoulou T et al (2002) Deletion of leucine-61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 100:1026\u20131030","journal-title":"Blood"},{"key":"32_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/pd.1970120910","volume":"12","author":"M Boer De","year":"1992","unstructured":"De Boer M, Bolscher BGJM, Sijmons RH et al (1992) Prenatal diagnosis in a family with X-linked chronic granulomatous disease with the use of the polymerase chain reaction. Prenat Diagn 12:773\u2013777","journal-title":"Prenat Diagn"},{"key":"32_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/pd.296","volume":"22","author":"M Boer De","year":"2002","unstructured":"De Boer M, Singh V, Dekker J et al (2002) Prenatal diagnosis in two families with autosomal, p47-phox-deficient chronic granulomatous disease due to a novel point mutation in NCF1. Prenat Diagn 22:235\u2013240","journal-title":"Prenat Diagn"},{"key":"32_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/252460","volume":"2012","author":"N Rieber","year":"2012","unstructured":"Rieber N, Hector A, Kuijpers TW et al (2012) Currents concepts of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol 2012:252460","journal-title":"Clin Dev Immunol"},{"key":"32_CR28","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1542\/peds.114.2.462","volume":"114","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Rosenzweig SD, Kleiner DE et al (2004) Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114:462\u2013468","journal-title":"Pediatrics"},{"key":"32_CR29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jaci.2014.04.014","volume":"134","author":"A Magnani","year":"2014","unstructured":"Magnani A, Brosselin P, Beaut\u00e9 J et al (2014) Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol 134:655\u2013662","journal-title":"J Allergy Clin Immunol"},{"key":"32_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/422993","volume":"39","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Wesley R, De Carlo ES et al (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39:692\u2013699","journal-title":"Clin Infect Dis"},{"key":"32_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.clim.2007.09.008","volume":"126","author":"B Martire","year":"2008","unstructured":"Martire B, Rondelli R, Soresina A et al (2008) Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin Immunol 126:155\u2013164","journal-title":"Clin Immunol"},{"key":"32_CR32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T G\u0171ng\u0151r","year":"2014","unstructured":"G\u0171ng\u0151r T, Teira P, Slatter M et al (2014) Reduced intensity conditioning and HLA-matched haematopoietic stem-cell transplantation in patients with chronic granulomatous disease ; a prospective multicentre study. Lancet 383:436\u2013448","journal-title":"Lancet"},{"key":"32_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1182\/blood-2016-03-704015","volume":"128","author":"B Morillo-Gutierrez","year":"2016","unstructured":"Morillo-Gutierrez B, Beier R, Rao K et al (2016) Treosulfan based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicentre experience. Blood 128:440\u2013448","journal-title":"Blood"},{"key":"32_CR34","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.jaci.2013.05.031","volume":"132","author":"T Cole","year":"2013","unstructured":"Cole T, Pearce MS, Cant AJ et al (2013) Clinical outcome in children with chronic granulomatous disease managed conservatively or with hematopoietic stem cell transplantation. J Allergy Clin Immunol 132:1150\u20131155","journal-title":"J Allergy Clin Immunol"},{"key":"32_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/156652307780859044","volume":"7","author":"MG Ott","year":"2007","unstructured":"Ott MG, Seger R, Stein S et al (2007) Advances in the treatment of chronic granulomatous disease by gene therapy. Curr Gene Ther 7:155\u2013161","journal-title":"Curr Gene Ther"},{"key":"32_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/nm.2088","volume":"16","author":"S Stein","year":"2010","unstructured":"Stein S, Ott MG, Schultze-Strasser S et al (2010) Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16:198\u2013204","journal-title":"Nat Med"},{"key":"32_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.drudis.2010.01.006","volume":"15","author":"M Nakayama","year":"2010","unstructured":"Nakayama M (2010) Homologous recombination in human iPS and ES cells for use in gene correction therapy. Drug Discov Today 15:198\u2013202","journal-title":"Drug Discov Today"},{"key":"32_CR38","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nrg2842","volume":"11","author":"FD Urnov","year":"2010","unstructured":"Urnov FD, Rebar EJ, Holmes MC et al (2010) Genome editing with engineered zinc-finger nucleases. Nat Rev Genet 11:636\u2013646","journal-title":"Nat Rev Genet"},{"key":"32_CR39","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.1182\/blood-2010-12-328161","volume":"117","author":"J Zou","year":"2011","unstructured":"Zou J, Sweeney CL, Chou BK et al (2011) Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting. Blood 117:5561\u20135572","journal-title":"Blood"},{"key":"32_CR40","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.copbio.2012.01.013","volume":"23","author":"C Mussolino","year":"2012","unstructured":"Mussolino C, Cathomen T (2012) TALE nucleases: tailored genome engineering made easy. Curr Opin Biotechnol 23:644\u2013650","journal-title":"Curr Opin Biotechnol"},{"key":"32_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1182\/bloodadvances.2016001214","volume":"4","author":"RK Merling","year":"2017","unstructured":"Merling RK, Kuhns DB, Sweeney CL et al (2017) Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease. Blood Adv 4:270\u2013278","journal-title":"Blood Adv"},{"key":"32_CR42","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.exphem.2015.06.002","volume":"43","author":"R Flynn","year":"2015","unstructured":"Flynn R, Grundmann A, Renz P et al (2015) CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells. Exp Hematol 43:838\u2013848","journal-title":"Exp Hematol"}],"container-title":["Methods in Molecular Biology","NADPH Oxidases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9424-3_32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T07:05:35Z","timestamp":1721372735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9424-3_32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493994236","9781493994243"],"references-count":42,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9424-3_32","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}